MIM
GSK icon

Martin Investment Management’s GSK GSK Stock Holding History

Martin Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,728
Closed -$933K – 51
2023
Q3 		$933K Buy
25,728
+11,148
+76% +$396K 0.28% 33
2023
Q2 		$520K Hold
14,580
– – 0.15% 40
2023
Q1 		$519K Hold
14,580
– – 0.15% 41
2022
Q4 		$512K Sell
14,580
-4,360
-23% -$145K 0.16% 36
2022
Q3 		$557K Buy
+18,940
New +$718K 0.2% 34

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martin Investment Management's GSK Position: Q4 2023 in Review

Martin Investment Management sold out of GSK (GSK) in Q4 2023, closing a stake of 25,728 shares — an estimated $933K sold.

Martin Investment Management first reported a position in GSK in Q3 2022 and held it in 5 quarters. The position peaked at $933K in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Martin Investment Management reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Martin Investment Management sold 25,728 GSK shares in Q4 2023, an estimated $933K.
  • Martin Investment Management first reported a position in GSK in Q3 2022 and held it in 5 quarters.
  • Martin Investment Management's GSK position peaked at $933K in Q3 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Martin Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.